Literature DB >> 20654227

[Analysis of the esophageal cancer mortality in 2004 - 2005 and its trends during last 30 years in China].

Wen-qiang Wei1, Juan Yang, Si-wei Zhang, Wan-qing Chen, You-lin Qiao.   

Abstract

OBJECTIVE: To describe the mortality of esophageal cancer (EC) in China during 2004 - 2005, and its trends over past 30 years.
METHODS: The Third National Retrospective Sampling Survey of Death Causes in 2004 - 2005 was covered 142 660 482 person years (72 970 241 person years in male, 69 690 241 person years in female; 47 899 806 person years in urban, 94 760 676 person years in rural). All death records of EC cases were selected. Crude, age-adjusted mortality, the proportion to all cancer deaths, and age-standardized death rate by Chinese standard population (CASR) and world standard population (WASR) were calculated. The statistic indexes of mortality were compared with those of previous retrospective death surveys in 1973 - 1975 and 1990 - 1992.
RESULTS: During 2004 - 2005, the crude death rate of EC was 15.21/100 000 (21 694/142 660 482), CASR was 9.98/100 000, EC death accounted for 11.19% (21 694/193 841) and ranked fourth of all cancer death causes. The CASR of male (14.32/100 000, 15 067 cases) was higher than that of female (5.75/100 000, 6627 cases). In rural areas, there were 16 437 deaths caused by EC with CASR of 12.01/100 000, it was higher than in urban areas (CASR was 6.48/100 000, 5257 deaths). There were little different of EC mortality among Eastern, Central and Western areas in China. EC crude death rate in Eastern was the highest with rate of 16.67/100 000 (8761/52 556 694) and the lowest rate was 12.92/100 000 (5209/40 322 563) in Western area. EC crude death rate was increased by age increasing and reached the peak with mortality of 180.55/100 000 (1984/1 098 885) at age group of 80-. The CASR of EC was reduced by 41.64% compared with the first survey (CASR was 17.10/100 000) in 1973 - 1975, and reduced by 33.56% compared with the second survey (CASR was 15.02/100 000) in 1990 - 1992.
CONCLUSION: Although the EC mortality has dropped obviously in the past three decades, it is still the main cancer burden, especially in rural areas. EC prevention and control should be focused on the rural high risk areas in China in future.

Entities:  

Mesh:

Year:  2010        PMID: 20654227

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  14 in total

1.  Cost-benefit analysis of esophageal cancer endoscopic screening in high-risk areas of China.

Authors:  Juan Yang; Wen-Qiang Wei; Jin Niu; Zhi-Cai Liu; Chun-Xia Yang; You-Lin Qiao
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

2.  Nicotine upregulates microRNA-21 and promotes TGF-β-dependent epithelial-mesenchymal transition of esophageal cancer cells.

Authors:  Yi Zhang; Tiecheng Pan; Xiaoxuan Zhong; Cai Cheng
Journal:  Tumour Biol       Date:  2014-04-23

3.  Incidence and mortality rate of esophageal cancer has decreased during past 40 years in Hebei Province, China.

Authors:  Yutong He; Yan Wu; Guohui Song; Yongwei Li; Di Liang; Jing Jin; Denggui Wen; Baoen Shan
Journal:  Chin J Cancer Res       Date:  2015-12       Impact factor: 5.087

4.  The lag effect of water pollution on the mortality rate for esophageal cancer in a rapidly industrialized region in China.

Authors:  Chengdong Xu; Dingfan Xing; Jinfeng Wang; Gexin Xiao
Journal:  Environ Sci Pollut Res Int       Date:  2019-09-09       Impact factor: 4.223

5.  Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China.

Authors:  Wen-Qiang Wei; Zhi-Feng Chen; Yu-Tong He; Hao Feng; Jun Hou; Dong-Mei Lin; Xin-Qing Li; Cui-Lan Guo; Shao-Sen Li; Guo-Qing Wang; Zhi-Wei Dong; Christian C Abnet; You-Lin Qiao
Journal:  J Clin Oncol       Date:  2015-05-04       Impact factor: 44.544

6.  Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis.

Authors:  Jiening Dun; Xueyan Chen; Haixia Gao; Yan Zhang; Huajun Zhang; Yongjian Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-02

7.  High expression of transient potential receptor C6 correlated with poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Shui-Shen Zhang; Jing Wen; Fu Yang; Xiao-Li Cai; Hong Yang; Kong-Jia Luo; Qian Wen Liu; Rong-Gui Hu; Xuan Xie; Qing-Yuan Huang; Jun Ying Chen; Jian Hua Fu; Yi Hu
Journal:  Med Oncol       Date:  2013-05-18       Impact factor: 3.064

8.  Overexpression of transient receptor potential vanilloid 2 is associated with poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Kun Zhou; Shui-Shen Zhang; Yan Yan; Song Zhao
Journal:  Med Oncol       Date:  2014-05-31       Impact factor: 3.064

9.  Abnormal MGMT promoter methylation may contribute to the risk of esophageal cancer: a meta-analysis of cohort studies.

Authors:  Jia-Jun Zhao; Hong-Yu Li; Di Wang; Hui Yao; Da-Wei Sun
Journal:  Tumour Biol       Date:  2014-10

10.  Investigation of tumor suppressing function of CACNA2D3 in esophageal squamous cell carcinoma.

Authors:  Yan Li; Cai-Lei Zhu; Chang-Jun Nie; Jiang-Chao Li; Ting-ting Zeng; Jie Zhou; Jinna Chen; Kai Chen; Li Fu; Haibo Liu; Yanru Qin; Xin-Yuan Guan
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.